In particular, serum PSMA-positive EV concentration has been successfully used to differentiate BPH from PCa and to distinguish tumors with GS ≤ 7 from those with GS ≥ 8 [128, 129]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.